Pre-revenue startup valuation is negotiated storytelling with structure, and the five methods founders and early investors actually use are more practical than any finance textbook suggests.
Ask most first-time founders how to value a startup with no revenue, and you'll get one of two answers: a blank stare or a number that came from nowhere in particular. Both are problems. Valuation at the pre-seed and seed stage is genuinely hard, but it's not arbitrary, and treating it as a pure negotiation with no framework is how founders give away too much equity or kill a deal before it starts. The methods below are the ones that actually show up in term sheets and angel conversations, not the discounted cash flow models your finance professor loved and that require revenue projections you simply don't have.
Dave Berkus, a Pasadena-based angel investor who has backed more than 140 companies, developed his method in the 1990s precisely because pre-revenue startups have nothing to discount. It assigns a dollar value, up to $500,000 each, to five qualitative milestones: the soundness of the idea, a working prototype, quality of the management team, strategic relationships, and product rollout or early sales. The theoretical maximum is $2.5 million pre-money. That cap reflects the market Berkus designed it for, and most investors adjust upward for today's seed round sizes, but the structure stays the same.
What Berkus actually built is a structured conversation starter. You can't fake your way through it. Either you have a working prototype or you don't. Either your founding team has relevant domain experience or it has a gap you need to explain. The method forces both sides to say out loud what they're actually valuing. A $2 million pre-money Berkus valuation on a two-person team with a prototype and one design partner says something specific about where the risk sits, and that specificity is precisely why it's worth using even when the numbers feel rough.
Scorecard and Comparables: Two Methods That Work Best Together
The Scorecard Method, developed by Bill Payne, a veteran U.S. angel investor and co-author of "Fool's Gold," starts with the average pre-money valuation for seed deals in your region and sector, then adjusts up or down based on how your startup compares across six factors: strength of the team, size of the opportunity, product or technology, competitive environment, marketing and sales channels, and need for additional investment. Team strength typically carries 30 percent of the total weight. At the pre-revenue stage, that weighting reflects something real: you're largely betting on execution capacity, not a validated business model. A founding team with a prior exit or deep technical expertise in a regulated sector will push the scorecard valuation meaningfully above the regional average.
Comparable transactions work alongside this. If three similar pre-revenue SaaS companies in your city raised seed rounds at $4 million to $6 million pre-money in the past 12 months, that range anchors your negotiation far better than any model. Carta and Crunchbase give you access to this data, though the granularity varies by market. Y Combinator's standard SAFE terms have also effectively set a global reference point for early-stage deals. When YC prices its batch companies at valuation caps of $5 million to $10 million, the wider market uses those numbers as a floor without always acknowledging it.
The VC Method: Working Backwards From Exit
Venture capitalists don't actually care much about your startup's current value. What they care about is what their ownership stake will be worth at exit, and whether that return justifies the risk of writing a check into a company with no revenue. The VC method makes this logic explicit. You start with a projected exit value, typically based on revenue multiples for comparable acquisitions or IPOs in your sector, then discount it back using a target return rate, usually somewhere between 20 and 40 times the investment for early-stage bets, and work backwards to a post-money valuation. If a VC wants 10x on a $1 million investment and believes your company could exit at $50 million in five years, they need roughly 20 percent ownership. The implied post-money valuation is $5 million, and that's the number they're anchored to before you walk in the room.
Knowing that logic changes the conversation. What it can't do is make the exit assumption solid. A $50 million exit projection for a pre-revenue startup is a guess dressed in arithmetic. Both sides usually know this, which is why the VC method sets a ceiling on valuation more than a floor. It's more useful for understanding how an investor is thinking than for producing a number you can defend on its own.
Risk Factor Summation
The Risk Factor Summation method starts from a baseline valuation drawn from regional comparables, then adjusts it across 12 risk categories: management, stage of business, legislative and political risk, manufacturing, sales and marketing, funding and capital risk, competition, technology, litigation, international risk, reputation, and potential for a lucrative exit. For each category you assign a score between minus two and plus two, and each point typically shifts the valuation by $250,000. The adjustments add up fast. A startup with strong management but severe regulatory exposure, say a medical device company navigating FDA pathways, can see those two factors alone swing the pre-money figure by $1 million in opposite directions.
The method's real value isn't the number it produces. It's the risk audit that forces both parties to name what they're actually worried about. A founder who walks through it honestly earns more credibility than one who presents a single clean figure with no acknowledgment of what could go wrong.
What No Method Can Tell You
Frankly, most valuation guides stop before the most important part. Pre-revenue startup valuation is only partially about which framework you use. The Berkus method and the scorecard method can look at the same startup and produce valuations that differ by $3 million, and both can be defensible. What closes that gap is negotiating leverage, and leverage comes from alternatives. Two term sheets in hand and your valuation goes up. Two weeks from running out of money with one investor at the table, and no framework protects you.
Know at least two of these methods well enough to walk through them out loud with an investor. Use comparables to anchor the conversation in reality. Run the VC method in reverse so you understand what return your investor needs and what ownership that implies before you agree to a cap. These aren't formulas that produce a right answer. They're lenses that give you a defensible position in a negotiation that would otherwise have no structure at all.
One thing worth saying directly: the number on the term sheet matters less than most first-time founders think. Dilution terms, pro-rata rights, and the quality of the investor sitting across from you will shape the company's trajectory more than whether your pre-money lands at $4 million or $5 million. Get the valuation into a reasonable range using the tools above, then spend the rest of your energy deciding who's actually in the round.
Also read: How to Build a SaaS Pricing Strategy That Scales From Startup to Enterprise • How to Build a Pitch Deck That Gets You Into the Room With Tier-1 VCs • Build a SaaS Customer Feedback Loop That Actually Moves Your Roadmap
